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Epilepsy is not a single disorder, but a collection of disorders that all are characterized by 
episodic abnormal synchronous electrical activity in the brain. This abnormal activity 
represents a disturbance of the balance between excitatory and inhibitory neurotransmission. 
The majority (50%) of epilepsies are cryptogenic, meaning there is a presumptive but no 
identifiable underlying etiology.  Approximately 20% of epilepsies have an identifiable cause 
(i.e. they are symptomatic) and are usually a result of trauma to the head, stroke, brain 
tumours, or infections. The remaining 30% are idiopathic, meaning there is no apparent 
underlying cause (Berg et al., 1999). However, as they are usually associated with a family 
history of similar seizures, they are mostly considered to be genetic. Mutations in over 70 
genes have been found to cause epilepsy (Noebels, 2003). Given the dependence of seizures on 
synaptic transmission and neuronal excitability, it is not surprising that many of these 
mutations affect the function of ion channels. Since the identification of the first epilepsy-
causing ion channel mutation, scientists have come a long way in the understanding of the 
pathogenesis of the disease. This chapter deals with some of the main questions that have been 
asked, and looks at some of the proposed answers to the questions. How do mutations in 
certain ion channels lead to hyperexcitability and seizures? Why do mutations in one ion 
channel cause a particular epilepsy syndrome? Why are the seizures often initiated during 
specific physiological events? And why do most of the childhood epilepsies remit with age? 
Furthermore, ion channels as targets for antiepileptic drugs will be discussed. 
2. Idiopathic epilepsies 
In most cases genetic epilepsy syndromes have a complex rather than a simple inheritance 
pattern. Although the epilepsies described here are thought to be monogenic, not even those 
considered inherited in a dominant fashion have a penetrance of 100%. Mutations within the 
same gene can result in clinically distinct phenotypes. Variable expressivity is also a 
common feature of inherited epilepsy demonstrated by family members with the same 
mutation that exhibit differences in the clinical severity of the disease (Hayman et al., 1997). 
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On the other hand, some of the disorders display locus heterogeneity where mutations in 
distinct genes result in the same syndrome. This indicates that other factors beside the 
primary mutation influence the clinical manifestation of the epilepsy, e.g. environmental 
factors, developmental events, or differences in inheritance of genetic susceptibility alleles. 
The latter is supported by mouse models where differences between the genetic 
backgrounds of two mouse strains influence the severity of a disease caused by the same 
sodium channel mutation (Bergren et al., 2005). 
Unfortunately, discovery of the responsible gene for an epilepsy syndrome have not led to a 
prompt understanding of the pathogenesis of the disease. Many of the mutated channels 
have been characterized in expression systems, but only in some cases have this led to a 
better understanding of the disease. In other cases this have led to more confusion, as some 
mutations in a particular channel are found to enhance channel function while others 
appear to cause a loss of function, even though the clinical manifestation are similar. There 
are also large discrepancies between results depending on the expression system used to 
characterize the channels. The mutated channel can e.g. show enhanced function when 
expressed in Xenopus laevis oocytes, while the opposite is shown when expressed in 
mammalian cells (Meadows et al., 2002). To make it even more difficult, it has been 
demonstrated that depending on the type of neuron in which a mutated channel is 
expressed, it can have strikingly different effects on the excitability of the cell (Waxman, 
2007). While a mutation can make one type of neuron hyperexcitable, the same mutation can 
make another neuron hypoexcitable. So changes in neuronal fuction are not necessarily 
predictable solely from the change in the behaviour of the mutated channel itself, but have 
to be considered in the cell background in which the mutated channel is expressed. Further, 
depending on whether a mutated channel mainly is expressed in excitatory or inhibitory 
neurons, it can have completely opposite effects on the excitability status of the neuronal 
network (Yu et al., 2006).  
The ion channel mutations are bound to cause relative subtle changes in neuronal function. 
Mutations that cause dramatic changes would likely result in a more severe phenotypes or 
lethality. The mutations apparently allow normal behaviour under most circumstances, but 
disturb the equilibrium between excitatory and inhibitory neuronal networks, so that small 
external perturbations such as fever are sufficient to break the homeostasis and induce 
seizures. 
3. Mutations in sodium channel subunit genes 
3.1 Voltage-gated sodium channels 
Voltage-gated sodium channels play an essential role in the initiation and propagation of 
action potentials. These channels open as the membrane depolarizes and inactivate within a 
few milliseconds of opening. As the membrane polarizes again, the inactivation is removed 
and a second depolarizing stimulus is able to reopen the channel.  
Sodium channels are large, multimeric complexes composed of an ǂ subunit and one or 
more auxiliary ǃ subunits. The ǂ subunit has four homologous domains, each consisting of 
six transmembrane helices. The ǃ subunit has one transmembrane segment and an 
extracellular domain with an immunoglobulin-like fold and belongs to the Ig superfamily of 
cell adhesion molecules (CAMs) (Catterall, 2000). The association with ǃ subunits modulate 
cell surface expression and localization, voltage-dependence and kinetics of activation and 
inactivation, as well as cell adhesion and association with signalling and cytoskeletal 
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molecules (Patino and Isom, 2010). Nine ǂ subunits (NaV1.1 – NaV1.9 encoded by SCN1A-
SCN11A) and four ǃ subunits (encoded by SCN1B-SCN4B) have been characterized so far. 
In addition, the enigmatic NaX channel, which appears not to be gated by voltage but rather 
by sodium, is encoded by the SCN7A gene (previously assigned as SCN6A) (Hiyama et al., 
2002). NaV1.1, NaV1.2, NaV1.3 and NaV1.6 are the sodium channel ǂ subunits most 
abundantly expressed in the brain (Yu and Catterall, 2003).   
3.2 GEFS+ and SMEI 
Febrile seizures, i. e. seizures induced by elevated body temperature, affect approximately 
3% of children under 6 years of age and are by far the most common seizure disorder. 
Generalized Epilepsy with Febrile Seizures Plus (GEFS+) is an autosomal dominant epileptic 
syndrome where the febrile seizures may persist beyond 6 years of age and which may be 
associated with afebrile generalized seizures (Scheffer and Berkovic, 1997). The disease has a 
penetrance of approximately 60%. In 1998, GEFS+ was linked to mutation in SCN1B, the 
voltage-gated sodium channel ǃ1 subunit gene (Wallace et al., 1998). GEFS+ can also result 
from mutations in the sodium channel ǂ subunit genes SCN1A (Escayg et al., 2000) and 
SCN2A (Sugawara et al., 2001), and from mutations in the GABRG2 gene which encodes the 
Ǆ2 subunit of the GABAA receptor (Baulac et al., 2001). Heterozygous mutations in SCN1A 
can also result in Severe Myoclonic Epilepsy of Infancy (SMEI), also known as Dravet 
syndrome (Claes et al., 2001). This rare form of epilepsy is characterized by generalized 
tonic, clonic, and tonic-clonic seizures that are initially induced by fever, light, sound, or 
physical activity and typically begin around 6-9 months of age. Later, SMEI patients also 
manifest other seizure types including absence, myoclonic, and simple and complex partial 
seizures. Psychomotor development stagnates around the second year of life and the 
patients often respond poorly to antiepileptic drugs. The disorder usually occurs in isolated 
patients as a result of de novo mutations (Claes et al., 2003; Ohmori et al., 2002).   
3.3 How mutations in sodium channels can cause seizures 
As sodium channels are responsible for the upstroke of the action potential one might 
expect that epilepsy-causing mutations in sodium channel genes increase the activity of the 
channel, thereby allowing increased influx of sodium ions and consequently neuronal 
hyperexcitability. Indeed, biophysical analyses of the mutant channels have shown that 
several of the mutations are gain-of-function mutations that increase sodium currents, e. g. 
by impairing inactivation or by causing a hyperpolarizing shift in the voltage-dependence of 
the channel (Lossin et al., 2002; Spampanato et al., 2003; Spampanato et al., 2004). The first 
identified GEFS+ mutation, a C121W missense mutation that disrupts a conserved 
disulphide bridge in the extracellular Ig domain of the ǃ1 subunit, causes subtle changes in 
modulation of sodium channel function and alter the ability of ǃ1 to mediate protein-protein 
interactions that are critical for channel localization (Meadows et al., 2002; Wallace et al., 
1998). Electrophysiological and biochemical studies on the mutant C121W ǃ1 subunit co-
expressed with NaV1.2 or NaV1.3 have shown that the C121W mutation causes a reduction 
in current rundown during high-frequency channel activation and increases the fraction of 
sodium channels that are available to open at subthreshold membrane potentials (Meadows 
et al., 2002). The mutation is therefore thought to enhance sodium channel function, thereby 
increasing neuronal excitability and predisposing to seizures. 
On the other hand, many of the characterized sodium channel mutations are found to cause 
attenuation of sodium current (Barela et al., 2006; Lossin et al., 2003; Sugawara et al., 2001). 
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While it seems like the mild phenotype of GEFS+ mostly is associated with missense 
mutations that alter the biophysical properties of the channels, the more severe SMEI 
phenotype is usually caused by nonsense or frameshift mutations that prevent production 
of functional channels (Claes et al., 2003; Claes et al., 2001; Nabbout et al., 2003; Ohmori et 
al., 2002). But how can loss-of-function mutations in a sodium channel cause epilepsy when 
reduced sodium current should lead to hypoexcitability rather than hyperexcitability? The 
answer seems to be related to the expression pattern of the channels. NaV1.1 is 
predominantly found in inhibitory interneurons and is thought to conduct most of the 
sodium current in these cells, whereas excitatory pyramidal neurons express only negligible 
levels of NaV1.1 (Ogiwara et al., 2007). Catterall and co-workers showed that 
haploinsufficiency of NaV1.1 channels in heterozygous knock-out mice led to a phenotype 
resembling that of SMEI (Oakley et al., 2009; Yu et al., 2006). In these mice, sodium currents 
in GABAergic interneurons in the hippocampus were substantially reduced, whilst the 
effect in pyramidal cells was much less severe. Loss of one SCN1A copy led to a reduction in 
action potential number, frequency and amplitude in the interneurons (Yu et al., 2006). 
Similarly, studies in several animal models carrying nonsense or missense mutations in 
SCN1A show impaired interneuron function (Martin et al., 2010; Mashimo et al., 2010; 
Ogiwara et al., 2007; Tang et al., 2009). These studies indicate that functional loss of one copy 
of SCN1A reduces the inhibitory function of GABAergic interneurons and enhances the 
excitability of downstream synaptic targets, thereby predisposing to epileptic seizures.  
But if this is true, how does the predicted changed NaV1.1 function in many of the patients 
lead to hyperexcitability when the consequence should be increased GABA action? One 
possibility is that enhanced sodium current in the interneurons causes too much inhibition, 
and that this leads to synchronization of the downstream synaptic targets, as has been 
suggested in the pathogenesis of autosomal dominant nocturnal frontal lobe epilepsy 
(ADNFL) (Klaassen et al., 2006) (discussed later). Another possibility is that the functional 
consequences of the mutations in vivo are different from that predicted after in vitro 
characterization of the mutant channels, and that all of the mutations actually cause a 
reduction of sodium current in inhibitory neurons. This is supported by studies on knock-
out mice lacking the ǃ1 subunit (Chen et al., 2004). These mice show downregulated NaV1.1 
expression, indicating that ǃ1 function might be necessary for normal expression of NaV1.1. 
As the inhibitory interneurons seem to be most affected by a reduction in NaV1.1, the 
consequences of the ǃ1 mutations might be reduced sodium current in interneurons rather 
than, or in addition to, increased NaV1.2 and NaV1.3 function. 
As mutations in SCN1A most often are associated with febrile seizures the mutations seem 
not to be sufficient to cause spontaneous seizure themselves. Why are the seizures triggered 
by fever? Why are the seizures most prevalent in young children? And what is the reason 
for the age-specific onset of SMEI? It is known that an increase in body temperature leads to 
an increase in the rate of respiration, especially in young children (Gadomski et al., 1994). 
This increased respiration can cause respiratory alkalosis in the immature brain, and 
alkalosis of brain tissue can lead to enhanced neuronal activity and to epileptoform activity 
(Lee et al., 1996). Studies on rat pups showed that seizure activity induced by hyperthermia 
had a well-defined pH threshold and that a rise in brain pH to the threshold level by 
injection of bicarbonate could provoke seizures (Schuchmann et al., 2006). By suppressing 
the alkalosis with a moderate elevation of ambient CO2 to 5%, seizures could be abolished 
within 20 seconds without affecting body temperature. Bicarbonate-induced pH changes 
and seizures could also be blocked by elevation of ambient CO2. In older rats, hyperthermia 
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only led to a moderate increase in the respiration rate and did not cause respiratory alkalosis 
and seizures (Schuchmann et al., 2006). Fever and the accompanying elevated pH and 
enhanced neuronal activity seem therefore to be the drop that makes the barrel overflow 
and induce the seizures. As several ion channels are sensitive to changes in pH (Jensen et al., 
2005; Prole et al., 2003), it will be interesting to see whether some mutations in sodium 
channel genes render the channels pH-sensitive, which could make the affected individuals 
specifically susceptible to febrile seizures.  
SMEI patients are normal until their first seizure that typically occurs around 6-9 months of 
age. This age-specificity may to be related to the time-specific expression of sodium 
channels. NaV1.1 is undetectable during prenatal and early postnatal development, a stage 
where NaV1.3 is preferentially expressed. NaV1.3 expression declines at the expression of 
NaV1.1 increases. An animal model of SMEI has shown that loss of inhibition and seizure 
onset correlates in time with an increase in NaV1.1 levels and decline in NaV1.3 levels 
(Oakley et al., 2009).  
4. Mutations in GABAA receptor subunit genes 
4.1 GABA receptors 
GABA is the major inhibitory neurotransmitter in the central nervous system. There are 
three types of GABA receptors: GABAA, GABAB, and GABAC. GABAA and GABAC 
receptors are ionotropic while GABAB receptors are G-protein coupled and often act by 
activating potassium channels. Most of the cortical inhibitory effects of GABA are mediated 
by GABAA receptors (Chebib and Johnston, 1999).  
The GABAA receptors are pentameric chloride channels formed by various combinations of 
different types of ǂ (ǂ1 to ǂ6), ǃ (ǃ1 to ǃ3), Ǆ (Ǆ1 to Ǆ3), ǅ, ǆ, Ǒ, θ, and ǒ (ǒ1 to ǒ3) subunits, that 
each have four transmembrane segments, M1 to M4 (Benarroch, 2007). The most prevalent 
subunit combination consists of ǂ1ǃ2Ǆ2 (McKernan and Whiting, 1996). The subunit 
composition determines the functional and pharmacological characteristics of the receptors 
(Meldrum and Rogawski, 2007; Sieghart and Sperk, 2002). Binding of GABA to the receptor 
triggers opening of the chloride channel, allowing rapid influx of chloride that hyperpolarizes 
the neuron and thereby decreases the probability of generation of an action potential.  
4.2 GEFS+ and ADJME 
As mentioned, GEFS+ can also result from mutation in the GABRG2 gene encoding the Ǆ2 
subunit of the GABAA receptor (Baulac et al., 2001). Mutations in the ǂ1 subunit gene 
(GABRA1) have been linked to Autosomal Dominant Juvenile Myoclonic Epilepsy (ADJME) 
(Cossette et al., 2002), an idiopathic epilepsy that is not associated with febrile seizures. This 
disorder typically manifests itself between the ages of 12 and 18 with myoclonic seizures 
occurring early in the morning and with additional tonic-clonic and absence seizures in 
some patients.  
4.3 How mutant GABAA receptor subunits can cause seizures 
It has been shown that mutations in the Ǆ2 subunit of the GABAA receptor cause retention of 
the receptor in the endoplasmatic reticulum (ER) (Harkin et al., 2002; Kang and Macdonald, 
2004). Similarly, the A322D mutation in the ǂ1 subunit causes rapid ER associated 
degradation of the subunit through the ubiquitin-proteasome system (Gallagher et al., 2007). 
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This reduced cell surface expression would result in decreased inhibitory GABAA receptor 
current, and consequently an increase in neuronal excitability and seizure susceptibility. But 
why are Ǆ2 mutations associated with febrile seizures? And why are mutations in ǂ1 not? 
Variations in temperature have effects on most cellular events. For example, synaptic vesicle 
recycling has been shown to be temperature dependent with increased temperature 
speeding both endo- and exocytosis, and there is evidence that inhibitory synaptic strength 
can be modulated within 10 min through recruitment of more functional GABAA receptors 
to the postsynaptic plasma membrane (Wan et al., 1997). Studies on cultured hippocamplal 
neurons showed that while trafficking of wild-type ǂ1ǃ2Ǆ2 receptors is slightly temperature 
dependent with a small decrease in surface expression after incubation at 40°C for 2h, 
trafficking of receptors with mutations in the Ǆ2 subunit is highly temperature dependent 
(Kang et al., 2006). Increases in temperature from 37°C to 40°C impaired trafficking and/or 
accelerated endocytosis of the mutant receptors within 10 min, suggesting that the febrile 
seizures may be a result of a temperature-induced reduction in GABA-mediated inhibition. 
The study also showed that the A322D mutation in the ǂ1 subunit did not cause a 
temperature-dependent reduction in surface expression, consistent with a resulting epilepsy 
syndrome not associated with febrile seizures (Kang et al., 2006).  
5. Mutations in potassium channel genes 
5.1 Kv7 channels and the M-current 
The Kv7 family of voltage-gated potassium channels consists of five members, Kv7.1 -5 (also 
termed KCNQ1-5). All five members share the general structure of voltage-gated potassium 
channels with four subunits that assemble to form functional tetramers. Each subunit 
consists of six transmembrane helices, S1-S6, and has a pore forming domain, which is 
formed by a P-loop between the fifth and the sixth helix. The P-loop contains the GYG 
(glycine-tyrosine-glycine) sequence, which is highly conserved among potassium channels 
and confers K+ selectivity. The fourth helix forms the voltage sensor; it contains several 
arginine residues and is therefore strongly positive. A S4-S5 linker in one subunit couples 
the voltage sensor to the intracellular activation gate in S6 of the adjacent subunit (Laine et 
al., 2003). Although heavily debated, it is believed that when the membrane potential 
depolarize, the voltage sensor is pushed out leading to bending of the S6 so potassium can 
enter the channel pore (Long et al., 2005).  
All Kv7 channels are strongly inhibited upon activation of muscarinic receptors and are 
hence called M-channels (Schroeder et al., 2000; Selyanko et al., 2000). The current 
conducted by these channels, the M-current, was first described in bullfrog sympathetic 
ganglia as a slowly activating, slowly deactivating, sub-threshold voltage-dependent K+ 
current that showed no inactivation (Brown and Adams, 1980). The Kv7 channels have slow 
activation and deactivation kinetics, and in line with other voltage-gated potassium 
channels they open upon membrane depolarization. However, the threshold for activation is 
low compared to most other channels, approximately -60 mV. Since the channels open at 
voltages that are around or below the threshold for generation of an action potential they 
allow potassium flow that opposes the depolarization required to generate action potentials, 
and hence make the neuron less excitable. If the M-channels remain open during excitation 
of the nerve, the spike frequency is dampened, whiles inhibition of the M-current by 
activation of muscarinic acetylcholine receptors enables repetitive firing (Hille, 2001).  
www.intechopen.com
Epileptic Channelopathies and Dysfunctional  
Excitability - From Gene Mutations to Novel Treatments 
 
199 
Kv7 channels are primarily localized at the axon initial segment, the site where synaptic 
inputs are integrated and action potentials are generated (Pan et al., 2006; Rasmussen et al., 
2007). Additionally, immunohistochemical studies have demonstrated a widespread pre-
synaptic distribution of some Kv7 channel subunits (Cooper et al., 2000), where they may 
play a role in depolarization-induced neurotransmitter release (Martire et al., 2004; Martire 
et al., 2007). Activation of pre-synaptic M-current may hyperpolarize the nerve endings, 
thus reducing Ca2+ influx through voltage-gated Ca2+ channels and limiting the amount of 
neurotransmitter released.  
5.2 Benign neonatal familial convulsions 
Benign Neonatal Familial Convulsions (BNFC) is a rare autosomal dominant idiopathic 
form of epilepsy. It is characterized by tonic-clonic seizures that typically begin around 
three days after birth and remit after 3-4 months. Yet ~16% of patients also experience 
seizures later in life (Ronen et al., 1993). BNFC is caused by mutations in the genes encoding 
Kv7.2 (Biervert et al., 1998; Singh et al., 1998) or Kv7.3 (Charlier et al., 1998).  
5.3 How mutations in Kv7.2 and Kv7.3 can cause BNFC 
All characterized mutations in Kv7.2 and Kv7.3 cause a reduction in M-current, either by 
changing the channel kinetics (Dedek et al., 2001), by altering the trafficking of the channel 
to the cell membrane (Schwake et al., 2000), or by decreasing the subunit stability 
(Soldovieri et al., 2006). The mutations usually cause a reduction in M-current of about 25% 
(Schroeder et al., 1998). Considering the role of Kv7 channels in controlling neuronal 
excitability, it is not surprising that a reduction in M-current can cause hyperexcitability and 
predispose to seizures. Several transgenic strategies have been employed to examine how 
Kv7.2 and Kv7.3 malfunction lead to BNFC. The traditional knock-out approach resulted in 
mice that died within a few hours after birth due to pulmonary atelectasis (collapse of the 
lung) (Watanabe et al., 2000). Even though BNFC often results from Kv7.2 
haploinsufficiency, heterozygous KCNQ2+/- mice did not experience neonatal seizures and 
appeared normal. They did, however, have increased susceptibility to chemically induced 
seizures (Watanabe et al., 2000). To overcome the postnatal lethality Dirk Isbrandt and 
colleagues developed mice conditionally expressing dominant-negative Kv7.2 subunits 
(Kv7.2-G279S) where expression of the transgene could be turned on after birth (Peters et al., 
2005). These mice showed spontaneous seizures, exhibited behavioural hyperactivity and 
had morphological changes in the hippocampus. Mark Leppert and co-workers developed 
orthologous mouse models carrying disease-causing mutations in the KCNQ2 (A306T) or 
KCNQ3 (G311V) gene (Singh et al., 2008). Mice heterozygous or homozygous for either 
mutation had reduced seizure threshold, but only mice homozygous for the mutations 
exhibited spontaneous seizures. The epileptic phenotype was dependent on the specific 
mutation, the genetic background, sex, and seizure model (Otto et al., 2009). Hence, none of 
these transgenic strategies have fully recapitulated the human condition but nevertheless 
provide us with important clues regarding the pathophysiology of BNFC. 
It can be questioned why the disease usually only is clinically manifested in neonates when 
mutations in the channels cause general hyperexcitability. One possible explanation for the 
age-dependent remission of seizures is related to the expression of Kv7 channels. There is 
evidence for a developmental upregulation of Kv7 channels (Weber et al., 2006), suggesting 
that a reduction in M-current of 25% might have a more prominent effect in the fetal brain 
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and that this reduction is not sufficient to cause seizures later in life when expression levels 
of Kv7 channels are higher.  
Another possible mechanism is related to developmental changes in GABA function. During 
the first weeks of life, GABA, the main inhibitory neurotransmitter in the adult brain, 
provides the main excitatory drive to immature hippocampal neurons (Ben-Ari, 2002). Due 
to delayed expression of a chloride exporter there is a high intracellular concentration of 
chloride that leads to a negative shift in the reversal potential for chloride ions, so opening 
of ionotropic GABA receptors leads to an efflux of negative chloride ions and therefore 
depolarization. When the chloride-extruding system becomes operative, chloride is 
efficiently transported out of the cell, and GABA begins to exert its conventional inhibitory 
action (Ben-Ari, 2002). Because of this, the inhibition in neonatal circuits appears mainly to 
be mediated through presynaptic control of neurotransmitter release. As Kv7 channels are 
involved in the release of neurotransmitters (Martire et al., 2004; Martire et al., 2007), it was 
proposed that these channels serve as the main inhibitor in neonates, and that attenuation of 
M-current due to mutations in Kv7.2 and Kv7.3 causes reduced inhibition that is sufficient 
to cause epilepsy (Peters et al., 2005). If Kv7 channels are expressed in GABAergic neurons, 
the reduced M-current would possibly also cause increased GABA release which further 
would increase excitability at this point of development.  It is also important to note that the 
neonatal brain is particularly prone to seizures (Holmes and Ben-Ari, 1998). As development 
continues and overall excitability decreases, reduced M-current apparently becomes less 
problematic and the seizures abate.  
Yet, if this is the fact, why do ∼16% of the patients experience seizures later in life after 
GABA has gained its inhibitory function? There is evidence to indicate that suppression of 
M-current within the first postnatal week can cause developmental defects, and that the 
resulting morphological changes in the brain, rather than reduced M-current causes the 
seizures in adulthood (Peters et al., 2005). In other words, it appears to become a 
symptomatic epilepsy with an idiopathic aetiology.  
6. Mutations in nAChR subunit genes 
6.1 Nicotinic acetylcholine receptors 
Nicotinic acetylcholine receptors (nAChRs) consist of five subunits that assemble to form 
functional pentamers. Each subunit consists of a long extracellular N-terminal domain, 
four transmembrane helices (TM1-TM4), and a short extracellular C-terminal end. The 
second transmembrane segment (TM2) from each subunit lines the channel pore. The 
amino acids that compose the TM2 are arranged in such a way that three rings of 
negatively charged amino acids are oriented toward the central pore of the channel. These 
provide a selectivity filter that ensures that only cations can pass through the pore. Brief 
exposure to high concentrations of Ach causes opening of the water-filled pore and 
permits an influx of Na+ and Ca2+ and an efflux of K+ (Waxham, 2003). After a few 
milliseconds, the receptor closes to a nonconducting state. Prolonged exposure to agonist 
causes desensitization of the channel, which stabilizes the receptor in an unresponsive, 
closed state (Dani and Bertrand, 2007). 
The neuronal nAChRs can be either homomeric, consisting of five ǂ subunits, or 
heteromeric with two ǂ subunits and three ǃ subunits. So far, 12 nAChR subunits expressed 
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in the brain have been identified (ǂ2-ǂ10 and ǃ2-ǃ4). The most widely distributed nAChRs 
in the human brain are the homomeric ǂ7 and the heteromeric ǂ4ǃ2. The biochemical, 
pharmacological and biophysical characteristic of the channels are dependent on the subunit 
composition (Dani and Bertrand, 2007). 
6.2 Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) is a focal epilepsy 
characterized by clusters of brief nocturnal motor seizures with hyperkinetic or tonic 
manifestations. Seizures typically occur very soon after falling asleep or during the early 
morning hours, initiated during stage 2 non-rapid-eye-movement (NREM) sleep. Onset 
usually occurs around age 10 and the seizures often persist through adult life. However, in 
most patients the seizures tend to peter out in adulthood.  
In 1995, a missense mutation (S248F) in the nAChR ǂ4 subunit gene (CHRNA4) was found 
to underlie ADNFLE (Steinlein et al., 1995). Additional disease causing mutations in this 
gene (Hirose et al., 1999; Steinlein et al., 1997), and mutations in the ǃ2 subunit gene 
(CHRNB2) (Phillips et al., 2001) have later been identified. Because ǂ4 and ǃ2 subunits 
combine, it is not strange that mutations in either subunit produce comparable epileptic 
symptoms. Almost every known mutation is found in the TM2 region of the two subunits. A 
common finding among the mutations is that the sensitivity to ACh is increased (Bertrand et 
al., 2002).  
6.3 How mutations in nAChRs can cause ADNFLE 
Stage 2 NREM sleep is characterized by the appearance of sleep spindles and slow waves, 
transient physiological rhythmic oscillations that are produced by synchronized synaptic 
potentials in cortical neurons. It appears that the seizure often arise from a sleep spindle that 
transforms into epileptic discharges (Picard et al., 2007). Thalamocortical circuits are thought 
to play a role in the generation of these sleep spindles.  
Thalamic relay neurons are reciprocally connected to cortical neurons by excitatory 
synapses. Both thalamic and cortical neurons also excite GABAergic interneurons of the 
nucleus reticularis, which in turn inhibit thalamic relay neurons thus forming a feedback-
loop (Kandel et al., 2000). The thalamic relay neurons have two different modes of signalling 
activity: a transmission mode during wakefulness and rapid eye movement (REM) sleep 
and a burst mode during NREM sleep. In the transmission mode, the resting membrane 
potential of the thalamic relay neurons is near the firing threshold and incoming excitatory 
synaptic potentials drive the neuron to fire in a pattern that reflects the sensory stimuli. 
During the burst mode the thalamic relay neurons are hyperpolarized and respond to brief 
depolarization with a burst of action potentials, which indicates that the thalamus is unable 
to relay sensory information to the cortex (Kandel et al., 2000). The thalamic relay neurons 
can be in different modes because they possess special Ca2+ channels named T-type 
channels. These channels are inactivated at the resting membrane potential but become 
available for activation when the cell is hyperpolarized, and can then be transiently opened 
by depolarization (Contreras, 2006). The interneurons of the nucleus reticularis that form 
synapses at the relay neurons hyperpolarize the relay neurons upon activation of GABAA 
receptors, thus removing the inactivation of the T-type Ca2+ channels. Incoming excitatory 
synaptic potentials can then trigger transient opening of the T-type Ca2+ channels and the 
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resulting influx of Ca2+ brings the neuron’s membrane potential above threshold. The cell 
now fires a burst of action potentials that produces the synchronized postsynaptic potentials 
in cortical neurons that cause the spindle waves seen on the electroencephalogram. When 
sufficient Ca2+ has entered the cell a Ca2+-activated K+ current is triggered that 
hyperpolarizes the relay neurons and terminate the spindle (Contreras, 2006). Because of the 
feedback loops from the relay neurons and cortical neurons that innervate the interneurons 
of the nucleus reticularis, these are again activated, which allows for another round of burst 
firing.  
There is a high expression of the ǂ4ǃ2 nAChR subtype in the thalamus and the subtype can 
be found diffusely distributed onto pyramidal cells and GABAergic interneurons in the 
cortex. The thalamic relay neurons and the nucleus reticularis receive input from two 
groups of cholinergic neurons in the upper brain stem: the pedunculopontine and 
laterodorsal tegmental nuclei (LDT). These are critical for keeping the thalamic relay 
neurons in transmission mode during wakefulness and REM sleep. The LDT releases Ach 
during NREM sleep at the time of an arousal that interrupts the sleep spindle oscillations 
through depolarization of thalamic relay neurons (Lee and McCormick, 1997). The cortex 
receives cholinergic input from neurons in the nucleus basalis of Meynert that enhance 
cortical response to incoming sensory stimuli (Kandel et al., 2000). 
After studying transgenic ADNFLE mice with heterozygous expression of an ADNFLE 
mutation (Chrna4S252F or Chrna4+264), Boulter and colleagues suggested that an Ach-
dependent sudden increase in the response of GABAergic cortical interneurons contributes 
to the epileptogenesis in ADNFLE patients (Klaassen et al., 2006). They showed that 
asynchronously firing cortical pyramidal cells got synchronized when relived from a large 
GABAergic inhibition triggered by cholinergic over-activation of mutant nAChRs in the 
cortical interneurons.  
Dani and Bertrand suggested that this, together with an increased positive response of 
cortical pyramidal cells through cholinergic stimulation of their hypersensitive ǂ4ǃ2 
nAChRs, contributes to induction of the seizures (Dani and Bertrand, 2007). As the cortical 
pyramidal cells project back to the thalamus, excitatory stimuli will be boosted on to the 
interneurons of the nucleus reticularis and the relay neurons and induce synchronous 
activity and seizures (Dani and Bertrand, 2007). 
In addition, PET studies using a high affinity ǂ4ǃ2 agonist have showed a clear difference in 
the pattern of the nAChR density in the brains of ADNFLE patients compared to control 
subjects (Picard et al., 2006). The studies showed that patients had increased ǂ4ǃ2 density in 
the epithalamus, the interpeduncular nucleus (IPN) of the ventral mesencephalon and in the 
cerebellum, while the density in the right dorsolateral prefrontal region was decreased. As 
the IPN projects to the LDT, the authors proposed that prolonged depolarizations in IPN 
neurons, because of both increased density of ǂ4ǃ2 and hypersensitive receptors, could 
result in over-activation of the LDT and consequently the thalamic relay neurons (Picard et 
al., 2006). At the time of arousals, ACh acting on sensitized thalamic relay neurons could 
prevent the normal arousal-induced interruption of the sleep spindle oscillations and 
transform them into pathological Thalamocortical oscillations, triggering epileptic seizures 
(Picard et al., 2006).  
Neither of these mechanisms excludes the others. In fact, they might work together yielding 
even stronger possibilities for induction of seizures.  
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7. Ion channel modulators as antiepileptic drugs 
Many of the antiepileptic drugs on the market today exert strong effects on ionic currents. 
Sodium channel blockers were used in the treatment of epilepsy as early as in 1940, and 
since then several other sodium channel blockers have been developed. Carbamazepine, 
first introduced in 1968, stabilizes the inactive conformation of sodium channels and is 
widely used in the treatment of partial and generalized tonic-clonic seizures. Lamotrigine 
blocks sodium channels in a voltage- and use-dependent manner and is efficient for partial, 
absence, myoclonic and tonic-clonic seizures (Kwan et al., 2001). Drugs that potentiate 
GABA receptor function, such as benzodiazepines, have also been used as anticonvulsants 
for several years. These act by binding to the interface between the ǂ and Ǆ subunits of the 
GABAA receptor, resulting in allosteric activation of the receptor (Kwan et al., 2001). Several 
established and novel antiepileptic drugs have been reported to act on various K+ currents, 
but none of them exert their main effect on potassium channels (Meldrum and Rogawski, 
2007). Carbamazepine also exerts an effect on nAChRs by blocking the open conformation of 
the channel and is very effective in treatment of patients with ADNFLE. This effect might be 
related to the fact that several of the disease causing mutations in CHRNA4 and CHRNA2 
increase the sensitivity to the drug (Ortells and Barrantes, 2002).  
The knowledge of how mutations in ion channels cause neuronal hyperexcitability and 
epilepsy has led to new therapeutic strategies for prevention of seizures. The mutated 
proteins serve as mechanistic proof of concept that pharmacological antagonization of the 
epilepsy causing mechanisms could have desirable effects on neuronal excitability. These 
mechanisms are not necessarily targeted for treatment of the respective epilepsy syndrome, 
but as they are showed to cause hyperexcitability in the affected patients, antagonizing 
drugs may reduce excitability in patients with other types of epilepsy. An excellent example 
of this is Retigabine (other names are Trobalt, Potiga, or Ezogabine), which was approved by 
both the European Medicines Agency and the U.S. Food and Drug Administration in 2011 as 
adjunctive treatment for partial onset seizures. It was originally synthesized as a GABA 
modulator, but it was later shown that its main molecular target is the neuronal Kv7 
channels (Main et al., 2000; Rundfeldt and Netzer, 2000; Wickenden et al., 2000). Retigabine 
induces a large hyperpolarizing shift in the voltage-dependence of activation of Kv7 
channels, accelerates the activation kinetics and slows deactivation kinetics. Enhancement of 
M-current would clearly be effective in prevention of seizures in BNFC patients, but 
mutations in the Kv7 channels might render them insensitive to such drugs, which hampers 
the use of Kv7 channel openers in the treatment of BNFC. The hypothesis of reduced NaV1.1 
current in the pathogenesis of GEFS+ and SMEI, together with its primary expression in 
inhibitory interneurons, indicates that this sodium channel subtype plays a role in reducing 
neuronal excitability (Ogiwara et al., 2007; Yu et al., 2006). This opens the intriguing 
possibility that selective NaV1.1 openers can function as anticonvulsants, even though 
sodium channel openers generally are known as epileptogenic substances.  
An understanding of the etiology of the epilepsy syndromes and the causal factors in 
individual patients are also critical for selection of the right medication. Sodium channel 
blockers, which normally would exhibit anticonvulsant properties, would clearly not be the 
right choice to treat patients with SMEI, where a lack of sodium current seems to be the 
underlying cause. Similarly, as too much inhibition seems to play a role in the pathogenesis 
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of ADNFLE, GABA receptor agonist might have a negative effect in these patients. In fact, 
Boulter and co-workers showed that the GABAA receptor antagonist picrotoxin, which 
normally exhibits convulsive properties, was efficient in preventing seizures in the ADNFLE 
mice (Klaassen et al., 2006). 
8. Conclusion  
As about 30% of all patients with epilepsy respond poorly to antiepileptic drugs, there is 
clearly a need for development of new therapies. The growing understanding of the 
epileptic channelopathies and the structural and functional characterization of the mutated 
channels provide several opportunities for creation of novel and improved drugs.  
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